Of all the lifestyle factors linked to Alzheimer’s risk, sleep is among the most compelling, and the most underappreciated. Years of short or broken sleep are linked to the biological changes behind Alzheimer’s disease.

The short version: poor sleep and Alzheimer’s feed each other. Sleep loss raises amyloid-beta and tau, the two proteins that define the disease, at least in the short term. Early Alzheimer’s changes, in turn, damage the brain systems that run sleep. What we do not yet have is a trial showing that better sleep prevents dementia.

Does poor sleep cause Alzheimer’s, or is it an early sign?

Probably both, which is what makes this research hard to read.

Alzheimer’s disease starts years before memory loss, and it reaches sleep early. Tau, the protein that forms tangles, appears early in the locus coeruleus, a brainstem hub for arousal.1 Later, the disease damages the suprachiasmatic nucleus, the brain’s master clock.2 So sleep changes can be a symptom of disease already under way. Among 142 cognitively normal adults, those with amyloid build-up already slept less efficiently, spending 80.4% of their time in bed asleep versus 83.7% (Ju, JAMA Neurology 2013).3

Poor sleep also seems to come first. The Whitehall II study followed 7,959 British adults for 25 years. Compared with seven hours a night, sleeping six hours or less at age 50 was linked to a 22% higher dementia risk, and at age 60 to a 37% higher risk. Short sleep at 50, 60 and 70 carried a 30% higher risk than seven hours at all three ages (Sabia, Nature Communications 2021).4 Measuring sleep decades before diagnosis makes it less likely, but not impossible, that early disease explains the short sleep.

All of this is observational. That is why the 2024 Lancet Commission did not add sleep to its 14 modifiable risk factors: the evidence was not yet strong enough.5 Still, sleep is a promising modifiable target, and the case for it keeps growing.

How does deep sleep help clear amyloid and tau?

In 2012, researchers working in mice described a brain-wide waste-clearance pathway, now called the glymphatic system.6 Cerebrospinal fluid flows along channels around blood vessels and washes through brain tissue, carrying waste such as amyloid-beta away.

A 2013 study in Science found that in sleeping mice, the space between brain cells grew by 60% and amyloid-beta cleared faster than during wakefulness.7 In 2024, though, another team measured clearance in mice a different way and found it was lower during sleep, not higher.8 The question is not settled.

Evidence in humans is indirect but growing:

Deep sleep also seems to matter over the long run. In the Framingham Heart Study, 346 adults over 60 had two overnight sleep studies about five years apart. Each percentage point of slow-wave sleep lost per year was linked to a 27% higher risk of dementia over the next 17 years (Himali, JAMA Neurology 2023).12

Key Point

Sleep probably helps the brain keep amyloid-beta and tau in check, through some mix of lower production and better clearance. The glymphatic system is well studied in mice but still debated, and its role in human Alzheimer’s is not yet known.

What does one night without sleep do to amyloid and tau?

These were short experiments in healthy people. Whether spikes like these add up to plaques and tangles over decades is unknown.

Is sleep apnea a dementia risk factor, and does CPAP help?

In obstructive sleep apnea, the airway repeatedly narrows or closes during sleep, breaking up sleep and dropping oxygen levels. A 2017 meta-analysis of six prospective studies found that people with sleep-disordered breathing were 26% more likely to develop cognitive impairment (Leng, JAMA Neurology 2017).16 In cognitively normal older adults followed for two years, more severe apnea was linked to faster change in spinal-fluid markers of amyloid build-up (Sharma, Am J Respir Crit Care Med 2018).17

Whether treatment lowers that risk is less clear:

Sleep apnea is worth treating for reasons that stand on their own, with possible brain benefits on top. A home sleep apnea test is a reasonable first step for many adults with suspected moderate to severe apnea; in-lab polysomnography remains the reference standard.20

Do sleeping pills raise dementia risk?

It depends on the drug, and the data are messier than the headlines.

Benzodiazepines such as lorazepam and alprazolam. A Quebec study of 1,796 people with Alzheimer’s and 7,184 controls linked past use to 51% higher odds of Alzheimer’s, and more than 180 daily doses to 84% higher odds (Billioti de Gage, BMJ 2014).21 But a U.S. study of 3,434 older adults found a small increase only at low use, not at the highest use, which argues against a direct cause (Gray, BMJ 2016).22 Insomnia and anxiety can be early symptoms of dementia, so the pills may partly be a marker. Long-term use for sleep is still rarely the right plan.

Anticholinergic sleep aids. Diphenhydramine and doxylamine, found in many “PM” products, are antihistamines with anticholinergic effects. In the same U.S. cohort, more than about three years’ worth of daily doses of strong anticholinergic drugs was linked to a 54% higher dementia risk, and these antihistamines were among the most common (Gray, JAMA Internal Medicine 2015).23 A large English study found 49% higher odds at the highest exposure, though there the link was clearest for antidepressants, bladder drugs and antipsychotics rather than antihistamines (Coupland, JAMA Internal Medicine 2019).24

For chronic insomnia, the recommended first treatment for all adults is cognitive behavioral therapy for insomnia (CBT-I), not a pill.25

Orexin receptor antagonists such as suvorexant block a wake-promoting signal. In a randomized study of 38 cognitively normal adults aged 45 to 65, a single bedtime dose of suvorexant lowered spinal-fluid amyloid-beta by about 10% to 20% compared with placebo. The 20 mg dose also lowered one measure of tau phosphorylation by 10% to 15%, though not p-tau217 (Lucey, Annals of Neurology 2023).26 This is investigational. No study has shown these drugs prevent Alzheimer’s, and they are not approved for that use.

How much sleep is best for brain health?

The National Sleep Foundation recommends 7 to 9 hours for most adults, and 7 to 8 hours after age 65.27 The brain data fit. In the UK Biobank, about seven hours was the sweet spot: both shorter and longer sleep were linked to cognitive decline over time (Li, Nature Aging 2022).28 Long sleep is harder to interpret, though, because it can reflect depression, illness or early brain changes.

Duration is not the whole story:

Wearables give rough estimates of these measures. When a sleep disorder is suspected, a formal sleep study is the better tool.

What can you do tonight?

First, here is how strong the evidence is behind each main claim.

What the evidence shows on sleep and Alzheimer’s risk
Claim Strength What it rests on
CBT-I is the right first treatment for chronic insomnia Strong Guideline based on randomized trials; proven for sleep, not yet for dementia25
Sleep loss raises amyloid-beta and tau in the short term Moderate Small controlled human studies with consistent results131415
Short sleep in midlife is linked to later dementia Moderate Large long-term cohorts; observational4
Sleep apnea is linked to cognitive impairment Moderate Meta-analysis of prospective studies16
Heavy anticholinergic use is linked to dementia Moderate Large observational studies2324
Treating sleep apnea prevents dementia Early Observational data; the best trial showed short-term effects at most1918
Sleep speeds glymphatic clearance in humans Early Conflicting mouse studies and indirect human imaging7810
Orexin-blocking drugs could help prevent Alzheimer’s Early One short biomarker study; investigational26

These steps are low-risk and worth starting now:

  1. Keep a steady sleep window. Aim for 7 to 8 hours asleep at about the same times every day, weekends included.27
  2. Take snoring seriously. Loud snoring, pauses in breathing, morning headaches or waking unrefreshed are reasons to get tested for sleep apnea.
  3. Treat insomnia with CBT-I first. Telehealth and digital programs make it easier to find.
  4. Check your nighttime medicines. Read “PM” labels for diphenhydramine or doxylamine. If you take a benzodiazepine regularly, do not stop it suddenly on your own; plan a gradual taper with your doctor.
  5. Adjust the basics. Get morning daylight, keep alcohol away from bedtime, stay active, and keep the bedroom dark and cool.

In practice, sleep is never an afterthought in my evaluations. A comprehensive brain health assessment looks at sleep habits, circadian rhythm and possible sleep-disordered breathing, including upper airway resistance syndrome, which often goes undiagnosed. Where it helps, we track relevant markers over time.

What to Do

Short sleep, snoring, unrefreshing sleep and daytime fatigue are not inconveniences to tolerate. They are modifiable risk factors worth taking seriously.

Common Questions

Can one bad night of sleep cause Alzheimer’s disease?

No. A sleepless night briefly raises amyloid-beta and tau, but there is no evidence that occasional bad nights cause Alzheimer’s. The concern is years of short, broken or irregular sleep.

Is poor sleep an early sign of Alzheimer’s?

It can be. Alzheimer’s changes reach the brain areas that control sleep years before memory problems appear. New, lasting sleep changes deserve attention, but most poor sleep has other causes, such as sleep apnea, insomnia, pain or medications.

Does treating sleep apnea lower dementia risk?

Possibly, but it is not proven. CPAP users have lower rates of dementia diagnoses in observational studies, while the best randomized trial found only small, short-lived effects on thinking.

Are over-the-counter sleep aids bad for the brain?

Many contain diphenhydramine or doxylamine, which have anticholinergic effects. Long-term, heavy use of strong anticholinergic drugs is linked to higher dementia risk, so nightly use is worth reviewing with your doctor.

Is the glymphatic system proven in humans?

Not fully. Human imaging shows waves of cerebrospinal fluid during deep sleep and slower clearance after sleep loss. Whether sleep speeds waste removal in people, and how much that matters for Alzheimer’s, is still debated.

Is sleeping longer better for brain health?

Not beyond a point. In large studies, both short and long sleep are linked to worse cognitive outcomes. A new need for much more sleep is worth mentioning to a doctor.

The Bottom Line

Sleep is when the brain appears to manage the same proteins that build up in Alzheimer’s disease, and years of short, broken or irregular sleep are linked to higher dementia risk.

Much of the evidence is observational, and no trial has shown that better sleep prevents dementia. But sleep is among the most modifiable risk factors, the steps are low-risk, and in my experience many patients feel better day to day once their sleep is addressed.

References

  1. Braak H, Thal DR, Ghebremedhin E, Del Tredici K. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol. 2011;70(11):960-969. doi:10.1097/NEN.0b013e318232a379
  2. Stopa EG, Volicer L, Kuo-Leblanc V, et al. Pathologic evaluation of the human suprachiasmatic nucleus in severe dementia. J Neuropathol Exp Neurol. 1999;58(1):29-39. doi:10.1097/00005072-199901000-00004
  3. Ju YE, McLeland JS, Toedebusch CD, et al. Sleep quality and preclinical Alzheimer disease. JAMA Neurol. 2013;70(5):587-593. doi:10.1001/jamaneurol.2013.2334
  4. Sabia S, Fayosse A, Dumurgier J, et al. Association of sleep duration in middle and old age with incidence of dementia. Nat Commun. 2021;12(1):2289. doi:10.1038/s41467-021-22354-2
  5. Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. The Lancet. 2024;404(10452):572-628. doi:10.1016/S0140-6736(24)01296-0
  6. Iliff JJ, Wang M, Liao Y, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci Transl Med. 2012;4(147):147ra111. doi:10.1126/scitranslmed.3003748
  7. Xie L, Kang H, Xu Q, et al. Sleep drives metabolite clearance from the adult brain. Science. 2013;342(6156):373-377. doi:10.1126/science.1241224
  8. Miao A, Luo T, Hsieh B, et al. Brain clearance is reduced during sleep and anesthesia. Nat Neurosci. 2024;27(6):1046-1050. doi:10.1038/s41593-024-01638-y
  9. Fultz NE, Bonmassar G, Setsompop K, et al. Coupled electrophysiological, hemodynamic, and cerebrospinal fluid oscillations in human sleep. Science. 2019;366(6465):628-631. doi:10.1126/science.aax5440
  10. Eide PK, Vinje V, Pripp AH, Mardal KA, Ringstad G. Sleep deprivation impairs molecular clearance from the human brain. Brain. 2021;144(3):863-874. doi:10.1093/brain/awaa443
  11. Ju YS, Ooms SJ, Sutphen C, et al. Slow wave sleep disruption increases cerebrospinal fluid amyloid-β levels. Brain. 2017;140(8):2104-2111. doi:10.1093/brain/awx148
  12. Himali JJ, Baril AA, Cavuoto MG, et al. Association between slow-wave sleep loss and incident dementia. JAMA Neurol. 2023;80(12):1326-1333. doi:10.1001/jamaneurol.2023.3889
  13. Shokri-Kojori E, Wang GJ, Wiers CE, et al. β-Amyloid accumulation in the human brain after one night of sleep deprivation. Proc Natl Acad Sci U S A. 2018;115(17):4483-4488. doi:10.1073/pnas.1721694115
  14. Lucey BP, Hicks TJ, McLeland JS, et al. Effect of sleep on overnight cerebrospinal fluid amyloid β kinetics. Ann Neurol. 2018;83(1):197-204. doi:10.1002/ana.25117
  15. Holth JK, Fritschi SK, Wang C, et al. The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans. Science. 2019;363(6429):880-884. doi:10.1126/science.aav2546
  16. Leng Y, McEvoy CT, Allen IE, Yaffe K. Association of sleep-disordered breathing with cognitive function and risk of cognitive impairment: a systematic review and meta-analysis. JAMA Neurol. 2017;74(10):1237-1245. doi:10.1001/jamaneurol.2017.2180
  17. Sharma RA, Varga AW, Bubu OM, et al. Obstructive sleep apnea severity affects amyloid burden in cognitively normal elderly: a longitudinal study. Am J Respir Crit Care Med. 2018;197(7):933-943. doi:10.1164/rccm.201704-0704OC
  18. Kushida CA, Nichols DA, Holmes TH, et al. Effects of continuous positive airway pressure on neurocognitive function in obstructive sleep apnea patients: the Apnea Positive Pressure Long-term Efficacy Study (APPLES). Sleep. 2012;35(12):1593-1602. doi:10.5665/sleep.2226
  19. Dunietz GL, Chervin RD, Burke JF, Conceicao AS, Braley TJ. Obstructive sleep apnea treatment and dementia risk in older adults. Sleep. 2021;44(9):zsab076. doi:10.1093/sleep/zsab076
  20. Kapur VK, Auckley DH, Chowdhuri S, et al. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(3):479-504. doi:10.5664/jcsm.6506
  21. Billioti de Gage S, Moride Y, Ducruet T, et al. Benzodiazepine use and risk of Alzheimer's disease: case-control study. BMJ. 2014;349:g5205. doi:10.1136/bmj.g5205
  22. Gray SL, Dublin S, Yu O, et al. Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study. BMJ. 2016;352:i90. doi:10.1136/bmj.i90
  23. Gray SL, Anderson ML, Dublin S, et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med. 2015;175(3):401-407. doi:10.1001/jamainternmed.2014.7663
  24. Coupland CAC, Hill T, Dening T, et al. Anticholinergic drug exposure and the risk of dementia: a nested case-control study. JAMA Intern Med. 2019;179(8):1084-1093. doi:10.1001/jamainternmed.2019.0677
  25. Qaseem A, Kansagara D, Forciea MA, et al. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;165(2):125-133. doi:10.7326/M15-2175
  26. Lucey BP, Liu H, Toedebusch CD, et al. Suvorexant acutely decreases tau phosphorylation and Aβ in the human CNS. Ann Neurol. 2023;94(1):27-40. doi:10.1002/ana.26641
  27. Hirshkowitz M, Whiton K, Albert SM, et al. National Sleep Foundation's sleep time duration recommendations: methodology and results summary. Sleep Health. 2015;1(1):40-43. doi:10.1016/j.sleh.2014.12.010
  28. Li Y, Sahakian BJ, Kang J, et al. The brain structure and genetic mechanisms underlying the nonlinear association between sleep duration, cognition and mental health. Nat Aging. 2022;2(5):425-437. doi:10.1038/s43587-022-00210-2
  29. Yiallourou SR, Cribb L, Cavuoto MG, et al. Association of the sleep regularity index with incident dementia and brain volume. Neurology. 2024;102(2):e208029. doi:10.1212/WNL.0000000000208029
  30. Pase MP, Himali JJ, Grima NA, et al. Sleep architecture and the risk of incident dementia in the community. Neurology. 2017;89(12):1244-1250. doi:10.1212/WNL.0000000000004373

Written and medically reviewed by Nadir Bilici, MD, DipIBLM. Published December 2025 · Medically reviewed on . What changed: Expanded and re-referenced to current research. See our editorial policy.